Bone Marrow Transplantation

Treatment Could Alleviate Debilitating Side Effects

Published in Blood Weekly, June 15th, 2000

Wasting response in humans as well as several forms of debilitating inflammation, among other side effects afflicting recipients of bone marrow transplantation may be significantly alleviated using a new treatment developed by scientists at Hadassah University Hospital and Enzo Biochem, Inc.

Such results were reported in a paper presented at a conference of leading medical scientists meeting in San Diego, California. The side effects are part of graft versus host disease (GvHD), an undesirable immune response mounted against an individual receiving a bone marrow stem cell transplant. This disease can occasionally lead to death. There is currently no effective...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-06-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry